EOLS — Evolus, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1570562 ·
Last close
$7.80
Market Cap
$515.19M
52W High
$9.31
52W Low
$3.86
ADV30
819,227
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 84,084,000 | 57,180,000 | -3,293,000 | -8,052,000 | 248,024,000 | 45,170,000 | 278,927,000 |
| Mar 2026 | 73,137,000 | 48,897,000 | -6,862,000 | -10,674,000 | 220,646,000 | 49,792,000 | 249,427,000 |
| Dec 2025 | 90,300,000 | 59,291,000 | -291,000 | 130,000 | 225,868,000 | 53,826,000 | 248,974,000 |
| Sep 2025 | 68,967,000 | 45,841,000 | -10,164,000 | -15,737,000 | 218,997,000 | 43,523,000 | 247,757,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,381,000
Investing CF
$-6,515,000
Financing CF
$5,559,000
CapEx
$-6,515,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.52
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-679,766,000
Inventory
$40,896,000
Receivables
$62,383,000
ST Investments
—
EBIT TTM
$-17,460,000
Pretax Income TTM
$-33,679,000
Interest Exp TTM
$16,219,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$316,488,000
EBITDA
$-12,774,000
Free Cash Flow
$-1,819,000
Enterprise Value
$637,469,440
Total Cash
$45,170,000
Total Debt
$164,804,000
Shares Out
66,050,440
Trailing EPS
$-0.53
Book Value
$-0.47
ROE
—
ROA
-5.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 297,176,000 | -37,600,000 | -51,641,000 | 225,868,000 | 248,974,000 | -23,106,000 | -42,265,000 |
| Dec 2024 | 266,274,000 | -27,235,000 | -50,420,000 | 232,569,000 | 227,047,000 | 5,522,000 | -17,999,000 |
| Dec 2023 | 202,085,000 | -44,976,000 | -61,685,000 | 188,998,000 | 209,687,000 | -20,689,000 | -34,008,000 |
| Dec 2022 | 148,616,000 | -59,575,000 | -74,412,000 | 177,983,000 | 159,484,000 | 18,499,000 | -84,912,000 |
TTM Snapshot
Revenues TTM
$301,791,000
NetIncome TTM
$-43,423,000
OpCashFlow TTM
—
Assets (Latest)
$220,646,000
Forward EPS
$0.28
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $7.80 · call volume: 1,131 · put volume: 19
Expected Move to 2027-01-15:
±$2.08
(26.67%) —
implied range
$5.72 –
$9.88
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | $514.65M | $9.97 | — |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | $510.23M | $52.00 | — |
| CBIO | CRESCENT BIOPHARMA, INC. | $524.47M | $14.12 | — |
| ALT | Altimmune, Inc. | $505.75M | $2.60 | — |
| NGNE | Neurogene Inc. | $530.30M | $26.50 | — |
News headlines (Yahoo Finance, 1h cache)
FDA Flags Evolus’ Jeuveau Instagram Promotion As Misleading, Seeks Corrective Action
2026-10-02 17:41 · Yahoo
Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes
2026-10-01 12:30 · Yahoo
Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future
2026-09-09 06:10 · Yahoo
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet
2026-08-27 13:55 · Yahoo
Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Surges 21% and Adjusted EBITDA ...
2026-08-06 05:07 · Yahoo
Evolus Q2 Earnings Call Highlights
2026-08-06 01:03 · Yahoo
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-10 20:05 · Yahoo
UTMD Trades at a Premium to the Industry: How to Play the Stock?
2026-10-08 17:02 · Yahoo
Following Heightened Competition from Botox, Xeomin, and Long-Acting Daxxify, New Study Evaluates Dysport (abobotulinumtoxinA) Revenue Trajectory Through 2034
2026-08-17 14:56 · Yahoo
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
2026-09-01 15:37 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.